140 related articles for article (PubMed ID: 1426765)
1. Tyrphostins: tyrosine kinase blockers as novel antiproliferative agents and dissectors of signal transduction.
Levitzki A
FASEB J; 1992 Nov; 6(14):3275-82. PubMed ID: 1426765
[TBL] [Abstract][Full Text] [Related]
2. Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors.
Gazit A; Yaish P; Gilon C; Levitzki A
J Med Chem; 1989 Oct; 32(10):2344-52. PubMed ID: 2552117
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine kinase inhibition: an approach to drug development.
Levitzki A; Gazit A
Science; 1995 Mar; 267(5205):1782-8. PubMed ID: 7892601
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Moloney murine leukemia virus replication by tyrphostins, tyrosine kinase inhibitors.
Esther A; Iftach S; Esther P
FEBS Lett; 1994 Mar; 341(1):99-103. PubMed ID: 8137930
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative effects of tyrosine kinase inhibitors (tyrphostins) on human bladder and renal carcinoma cells.
Sion-Vardy N; Vardy D; Rodeck U; Kari C; Levin RM; Malkowicz SB
J Surg Res; 1995 Dec; 59(6):675-80. PubMed ID: 8538164
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of topoisomerase I activity by tyrphostin derivatives, protein tyrosine kinase blockers: mechanism of action.
Aflalo E; Iftach S; Segal S; Gazit A; Priel E
Cancer Res; 1994 Oct; 54(19):5138-42. PubMed ID: 7923131
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of tyrosine kinases in the treatment of psoriasis.
Ben-Bassat H; Klein BY
Curr Pharm Des; 2000 Jun; 6(9):933-42. PubMed ID: 10828317
[TBL] [Abstract][Full Text] [Related]
8. [The lead generation of protein tyrosine kinase inhibitors by quantitative structure-activity relationship analysis].
Guo ZR; Goto S; Yang GZ; Terada H
Yao Xue Xue Bao; 1992; 27(2):90-5. PubMed ID: 1414376
[TBL] [Abstract][Full Text] [Related]
9. Tyrphostins. 2. Heterocyclic and alpha-substituted benzylidenemalononitrile tyrphostins as potent inhibitors of EGF receptor and ErbB2/neu tyrosine kinases.
Gazit A; Osherov N; Posner I; Yaish P; Poradosu E; Gilon C; Levitzki A
J Med Chem; 1991 Jun; 34(6):1896-907. PubMed ID: 1676428
[TBL] [Abstract][Full Text] [Related]
10. Dissection of T cell antigen receptor signaling using protein tyrosine kinase inhibitors.
Baldari CT; Telford JL
Eur J Immunol; 1994 May; 24(5):1046-52. PubMed ID: 8181516
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of the epidermal growth factor and HER2/neu receptors by tyrphostins.
Osherov N; Gazit A; Gilon C; Levitzki A
J Biol Chem; 1993 May; 268(15):11134-42. PubMed ID: 8098709
[TBL] [Abstract][Full Text] [Related]
12. Opposing effects of tyrosine kinase inhibitors on mineralization of normal and tumor bone cells.
Klein BY; Tepper SH; Gal I; Shlomai Z; Ben-Bassat H
J Cell Biochem; 1997 Jun; 65(3):420-9. PubMed ID: 9138097
[TBL] [Abstract][Full Text] [Related]
13. Tyrphostins. 3. Structure-activity relationship studies of alpha-substituted benzylidenemalononitrile 5-S-aryltyrphostins.
Gazit A; Osherov N; Posner I; Bar-Sinai A; Gilon C; Levitzki A
J Med Chem; 1993 Nov; 36(23):3556-64. PubMed ID: 7902440
[TBL] [Abstract][Full Text] [Related]
14. Tyrphostins suppress the growth of psoriatic keratinocytes.
Ben-Bassat H; Vardi DV; Gazit A; Klaus SN; Chaouat M; Hartzstark Z; Levitzki A
Exp Dermatol; 1995 Apr; 4(2):82-8. PubMed ID: 7640880
[TBL] [Abstract][Full Text] [Related]
15. Design of hypoxia-targeting protein tyrosine kinase inhibitor using an innovative pharmacophore 2-methylene-4-cyclopentene-1,3-dione.
Hori H; Nagasawa H; Uto Y; Ohkura K; Kirk KL; Uehara Y; Shimamura M
Biochim Biophys Acta; 2004 Mar; 1697(1-2):29-38. PubMed ID: 15023348
[TBL] [Abstract][Full Text] [Related]
16. Tyrphostins inhibit follicle-stimulating hormone-mediated functions in cultured rat ovarian granulosa cells.
Gomberg-Malool S; Ziv R; Re'em Y; Posner I; Levitzki A; Orly J
Endocrinology; 1993 Jan; 132(1):362-70. PubMed ID: 8380382
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of phospholipase D of human platelets by protein tyrosine kinase inhibitors.
Martinson EA; Scheible S; Presek P
Cell Mol Biol (Noisy-le-grand); 1994 Jul; 40(5):627-34. PubMed ID: 7526916
[TBL] [Abstract][Full Text] [Related]
18. Agonistic effects of tyrphostins on human peripheral mononuclear cells.
Lander HM; Levine DM; Novogrodsky A
Cell Immunol; 1992 Oct; 144(1):155-68. PubMed ID: 1394436
[TBL] [Abstract][Full Text] [Related]
19. Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins.
Párrizas M; Gazit A; Levitzki A; Wertheimer E; LeRoith D
Endocrinology; 1997 Apr; 138(4):1427-33. PubMed ID: 9075698
[TBL] [Abstract][Full Text] [Related]
20. Protein tyrosine kinase inhibitors as novel therapeutic agents.
Levitzki A
Pharmacol Ther; 1999; 82(2-3):231-9. PubMed ID: 10454200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
